Oncology and Haematology Department – Research
The oncology and haematology department see around 250 patients diagnosed with cancer or leukaemia per year. Our aim is to approach and consent every patient that enters the department on to a diagnosis specific clinical trial or biological study, where appropriate.
What do we do?
We are one of the main researchers into children’s cancers in the UK. We are one of four national experimental cancer medicine centres (ECMC), with a world-wide reputation for leading and participating in research to improve outcomes for children diagnosed with cancer.
We currently undertake a series of clinical trials ranging from Phase I to Phase III. The clinical trials team is split into two specialist groups, oncology and haematological malignancies. The team assist, co-ordinate and manage the delivery of clinical trial protocols, safety reporting, trial set-up, updates and closures and management of clinical trial data.
Who we are
The team is made up of Oncology Research Nurses, Clinical Trials Coordinators, Data Managers, and a Biological Samples Coordinator.
The Research nurse team co-ordinate the care of all children on Phase I and Phase II studies. They facilitate the consenting and sampling for Phase III trials and the biological and observational studies. They work as part of the multi-disciplinary team covering both inpatients and outpatients.
You can find more information about clinical trials here: